Evaluation of the non‑alcoholic fatty liver fibrosis score
in predicting short-term outcomes and severe coronary
artery disease in patients undergoing coronary computed
tomography angiography

Evaluation of the non‑alcoholic fatty liver fibrosis score in predicting short-term outcomes and severe coronary artery disease in patients undergoing coronary computed tomography angiography

Bibliographic Details
Main Authors:	Esra Colak, Burak Acar, Ozgur Cakir, Umut Celikyurt, Ozgur Baris, Akın Torun, Mustafa Eren Tosun, Aysen Agir, Tayfun Sahin, Ercument Ciftci
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-03-01
Series:	Advances in Interventional Cardiology
Subjects:	non-alcoholic fatty liver disease coronary artery disease coronary computed tomographic angiography non-alcoholic fatty liver disease fibrosis score cardiovascular outcomes
Online Access:	https://www.termedia.pl/Evaluation-of-the-non-alcoholic-fatty-liver-fibrosis-score-r-nin-predicting-short-term-outcomes-and-severe-coronary-r-nartery-disease-in-patients-undergoing-coronary-computed-r-ntomography-angiography,35,52664,1,1.html

Similar Items

Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease
by: Babak Baharvand-Ahmadi, et al.
Published: (2016-09-01)

The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography
by: Langroudi Taraneh Faghihi, et al.
Published: (2018-09-01)

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
by: Dong Hyun Sinn, et al.
Published: (2014-06-01)

Severity of Coronary Artery Disease associated with Non-Alcoholic Fatty Liver
by: Albair Abdulmaseh*, et al.
Published: (2021-01-01)

Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease
by: I. I. Vakalyuk, et al.
Published: (2018-03-01)

Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease
by: Yiwen Zhang, et al.
Published: (2019-11-01)

Relationship between the prevalence and severity of non‐alcoholic fatty liver disease and coronary artery disease: Findings from a cross‐sectional study of a referral center in northeast Iran
by: Arash Gholoobi, et al.
Published: (2022-05-01)

Histopathological Association of Non-alcoholic Fatty Liver Disease With Coronary Artery Atherosclerosis Grade
by: Behnaz Gholami, et al.
Published: (2024-02-01)

New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis
by: Georgiana-Diana Cazac, et al.
Published: (2022-08-01)

MENTAL HEALTH STATUS IN PATIENTS WITH STABLE CORONARY HEART DISEASE COMBINED WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: I.I. Vakalyuk
Published: (2017-07-01)

The peculiarities of adiponectin and resistin interrelationships with the components of metabolic syndrome in patients with coronary heart disease and concomitant nonalcoholic fatty liver disease
by: N. S. Mykhailovska, et al.
Published: (2016-10-01)

Coronary artery disease and non‐alcoholic fatty liver disease: Clinical correlation using computed tomography coronary calcium scans
by: Richard S Kirby, et al.
Published: (2021-03-01)

Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
by: Xiaomin Hu, et al.
Published: (2022-01-01)

TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients
by: Jianqi Zhao, et al.
Published: (2022-07-01)

The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study
by: Wen Dai, et al.
Published: (2021-08-01)

Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver
by: Toshihiro Niikura, et al.
Published: (2020-02-01)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
by: Rahul Sao, et al.
Published: (2017-07-01)

Predictive Performance of Ultrasound-Determined Non-Alcoholic Fatty Pancreas Disease Severity for Intermediate and High Risk of Coronary Heart Disease
by: Younghoon An, et al.
Published: (2019-11-01)

Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease? : Preliminary study in a local Indian population
by: Manopriya Thiruvagounder, et al.
Published: (2010-08-01)

Fighting liver fat
by: David Koeckerling, et al.
Published: (2020-08-01)

Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease
by: Michihiro Iwaki, et al.
Published: (2022-10-01)

The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
by: George Chen, et al.
Published: (2023-02-01)

TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han population
by: Qun Liu, et al.
Published: (2019-08-01)

Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease
by: A. Lum Han, et al.
Published: (2022-07-01)

Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis
by: Guohong-Liu, et al.
Published: (2019-11-01)

The beneficial effects of taurine in alleviating fatty liver disease
by: Qi Song, et al.
Published: (2021-02-01)

Association between non-alcoholic fatty liver disease and epicardial adipose tissue volume with cardiometabolic risk in coronary heart disease
by: Hany Samir Rasmy, et al.
Published: (2022-06-01)

Steatohepatitises: etiological variants, principles of diagnosis and management
by: D. T. Dicheva, et al.
Published: (2022-04-01)

The Frequency of Non-Alcoholic Fatty Liver Disease in Adults with Diabetes Mellitus
by: Raheel Akhtar Yousafzai, et al.
Published: (2023-08-01)

ANI scoring system – In differentiating alcoholic and non-alcoholic liver disease
by: Anitha G, et al.
Published: (2021-11-01)

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
by: Maryam Mahjoubin-Tehran, et al.
Published: (2021-08-01)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
by: Rahul Kumar, et al.
Published: (2020-04-01)

Research Progress of Pyroptosis in Fatty Liver Disease
by: Rongxuan Li, et al.
Published: (2023-08-01)

Serotonergic Regulation of Hepatic Energy Metabolism
by: Jiwon Park, et al.
Published: (2021-12-01)

Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study
by: Keishi Ichikawa, et al.
Published: (2021-01-01)

Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity
by: N. Matkovska
Published: (2020-06-01)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
by: Jong Hwa Choi, et al.
Published: (2020-10-01)

Association of Lipid Profile and Liver Parameters with Different Grades of Non-alcoholic Fatty Liver Disease
by: Drutpal Baghel, et al.
Published: (2023-03-01)